Canada markets close in 4 hours

Aldeyra Therapeutics, Inc. (ALDX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.1300-0.0300 (-0.72%)
As of 11:57AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 247.16M
Enterprise Value 120.00M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.06
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -3.41

Trading Information

Stock Price History

Beta (5Y Monthly) 1.52
52-Week Change 3-60.51%
S&P500 52-Week Change 322.38%
52 Week High 311.9700
52 Week Low 31.4200
50-Day Moving Average 33.6918
200-Day Moving Average 34.3685

Share Statistics

Avg Vol (3 month) 3585.16k
Avg Vol (10 day) 3410.27k
Shares Outstanding 559.41M
Implied Shares Outstanding 660.13M
Float 843.16M
% Held by Insiders 11.99%
% Held by Institutions 161.32%
Shares Short (Apr 15, 2024) 42.36M
Short Ratio (Apr 15, 2024) 43.08
Short % of Float (Apr 15, 2024) 44.79%
Short % of Shares Outstanding (Apr 15, 2024) 43.97%
Shares Short (prior month Mar 15, 2024) 41.83M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-14.29%
Return on Equity (ttm)-23.94%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -35.13M
Net Income Avi to Common (ttm)-30.01M
Diluted EPS (ttm)-0.6400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)83.04M
Total Cash Per Share (mrq)1.4
Total Debt (mrq)15.66M
Total Debt/Equity (mrq)13.81%
Current Ratio (mrq)6.50
Book Value Per Share (mrq)1.91

Cash Flow Statement

Operating Cash Flow (ttm)-30.85M
Levered Free Cash Flow (ttm)-83.51M